OTC Pharmaceuticals - Indonesia | Statista Market Forecast

The OTC Pharmaceuticals market in Indonesia is projected to generate revenue of US$3.00bn in 2024.
This market is expected to experience an annual growth rate of 7.94% (CAGR 2024-2029).
Among the various markets within the market, the largest one is Vitamins & Minerals, which is estimated to reach a market volume of US$743.70m in 2024.
When compared globally, the United States leads in terms of revenue generation, with a total of US$41.24bn in 2024.
In Indonesia, the per capita revenue in the OTC Pharmaceuticals market is predicted to be US$10.73 in 2024.
Furthermore, online sales are expected to contribute 27.08% of the total revenue in the OTC Pharmaceuticals market by 2024.
The demand for OTC Pharmaceuticals in Indonesia is driven by the growing middle class population and increasing awareness of self-medication.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in Indonesia has been experiencing significant growth in recent years. Customer preferences in the OTC Pharmaceuticals market in Indonesia have been shifting towards more accessible and convenient healthcare options. With an increasing number of people seeking self-care solutions, there is a growing demand for over-the-counter medications that can be easily purchased without a prescription. This trend is driven by several factors, including the rising awareness of health and wellness, the need for immediate relief from common ailments, and the desire for cost-effective healthcare options. In addition, the OTC Pharmaceuticals market in Indonesia is benefiting from the growing middle-class population, which has more disposable income and a higher propensity to spend on healthcare products. As the middle class expands, there is an increasing demand for OTC medications to address common health issues such as cough, cold, pain relief, and digestive problems. Another trend in the market is the increasing availability of OTC Pharmaceuticals through various distribution channels. Pharmacies and drugstores remain the primary channels for purchasing OTC medications, but there is also a growing presence of online pharmacies and e-commerce platforms. This shift towards online purchasing is driven by the convenience of doorstep delivery and the availability of a wider range of products. Local special circumstances in Indonesia also contribute to the growth of the OTC Pharmaceuticals market. The country has a large population, which provides a significant customer base for OTC medication manufacturers and retailers. Additionally, the government has been actively promoting self-care and over-the-counter medications as a means to reduce the burden on the healthcare system. This support from the government encourages the development and availability of OTC medications in the market. Underlying macroeconomic factors also play a role in the growth of the OTC Pharmaceuticals market in Indonesia. The country's stable economic growth and increasing disposable income levels have contributed to the affordability and accessibility of OTC medications. Furthermore, the rising healthcare expenditure and growing awareness of the importance of preventive healthcare have also fueled the demand for OTC Pharmaceuticals. In conclusion, the OTC Pharmaceuticals market in Indonesia is witnessing significant growth due to changing customer preferences, increasing availability through various distribution channels, local special circumstances, and underlying macroeconomic factors. As the market continues to evolve, it is expected to present lucrative opportunities for both local and international players in the industry.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The market has experienced significant growth during the past two decades, and pharma revenues worldwide totaled 1.48 trillion U.S. dollars in 2022.